CXCL8 and chronic obstructive pulmonary disease: Furthermore, Tiotropium reduces exacerbation frequency in COPD, but this effect does not appear to be due to a reduction in IL-8 systemic inflammation [48] and is able to control IL-8 release in epithelial cells in vitro [22, 49].